Fibromyalgia syndrome: Preventive, social and economic aspects;Gli aspetti preventivi, sociali ed economici della sindrome fibromialgica

Reumatismo

Volumn 60, Issue SUPPL. 1, 2007, Pages 70-77

  Altomonte, L ^a   Atzeni, F ^b   Leardini, G ^c   Marsico, A ^d   Gorla, R ^e   Casale, R ^f   Cassisi, G ^g   Stisi, S ^h   Salaffi, F ⁱ   Marinangeli, F ^j   Giamberardino, M A ^k   Di Franco, M ^l   Biasi, G ^m   Arioli, G ⁿ   Alciati, A ^b   Ceccherelli, F ^o   Bazzichi, L ^p   Carignola, R ^q   Cazzola, M ^r   Torta, R ^q   Buskila, D ^s   Spath, M ^t   Gracely, R H ^u   Sarzi Puttini, Piercarlo ^b   more..

^a S EUGENIO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SS Giovanni e Paolo Hospital   (Italy)

^d Hospital of Taranto   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f IRCCS   (Italy)

^g Rheumatology Branch   (Italy)

^h G RUMMO HOSPITAL   (Italy)

ⁱ UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^j UNIVERSITY OF L'AQUILA   (Italy)

^k UNIVERSITY OF CHIETI   (Italy)

^l SAPIENZA UNIVERSITY OF ROME   (Italy)

^m UNIVERSITY OF SIENA   (Italy)

ⁿ General Hospital of Pieve di Coriano   (Italy)

^o UNIVERSITY OF PADOVA   (Italy)

^p UNIVERSITY OF PISA   (Italy)

^q UNIVERSITY OF TURIN   (Italy)

^r Unit of Rehabilitative Medicine 'Hospital of Circolo'   (Italy)

^s BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^t LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^u UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

more..

Author keywords

Aspetti economici; Disabilit ; Disability. Parole chiave Prevenzione; Economic aspects; Prevention; Screening

Indexed keywords

ARTICLE; COST OF ILLNESS; DISABILITY; ECONOMICS; FIBROMYALGIA; HUMAN; INTERNET; MASS MEDIUM; SOCIOECONOMICS;

COST OF ILLNESS; DISABILITY EVALUATION; FIBROMYALGIA; HUMANS; INTERNET; MASS MEDIA; SOCIOECONOMIC FACTORS;

EID: 69249212539     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: 10.4081/reumatismo.2008.1s.70     Document Type: Article

References (52)

1. Hauser W, Zimer C, Felde E, Kollner V. What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association. Schmerz 2007.
2. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetic aspects of fibromyalgia syndrome. Arthtritis Res Ter 2006; 8: 218.
3. Martinez-Lavin M. Biology and therapy of fibromyalgia. Stress, the stress response system and fibromyagia. Arthtritis Res Ther 2007; 9: 216.
4. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of a multicenter criteria committee. Artrhritis Rheum1990; 33: 160-72.
5. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol 2005; 75: 6-21.
6. Webb R, Bramah T, Lunt M, Urwin M, Allison T, Symmons D. Prevalence and predictors of intense, chronic and disabling neck and back pain in the UK general population Spine 2003; 28: 1195-202.
7. Rao JK, Hootman JM. Prevention research and rheu-matic disease. Curr Opin Rheumatol 2004; 16: 119-24.
8. Gieseke T, Gracely RH, Willams DA, Geisser ME, Petzke FW, Clauw DJ. The relationship between depression, clinical pain and experimental pain in chronic pain cohort. Arthritis Rheum 2005; 52: 1574-84.
9. Theorell T, Harms-Ringdahl K, Ahlberg-Hulten G, Westin B. Psycosocial job factors and symptoms from the locomotor system-a multicausal analysis. Scand J Rehabil Med 1991; 23: 165-73.
10. McBeth J, Macfarlane GJ, Hunt IM, Silman AJ. Risk factors for persisten chronic widespread pain: a community-based study Rheumatology (Oxford) 2001; 40: 95-101.
11. Allison TR, Symmons DP, Brammah T, Haynes P, Rogers A, Roxby M, et al. Muscoloskeletal pain is more generalised among people from ethnic minorities than among white people in Greather Manchester. Ann Rheum Dis 2002; 61: 151-6.
12. Goldberg MS, Scott SC, Mayo NE. A review of the association between cigarette smoking and the development of non specific back pain and related outcomes Spine 2000; 25: 995-1014.
13. Walker-Bone K, Cooper C. Hard work never hurt anyone: or did it? A review of occupational associations with soft tissue musculoskeletal disorders of the neck and upper limb. Ann Rheum Dis 2005; 64:1391-6.
14. Bazzichi L, Rossi A, Giuliano T, De Feo F, Giacomelli C, Consensi A, et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 2007; 26: 2115-20.
15. Sarzi-Puttini P, Atzeni F, Turiel M, Furlan R, Vulpio L, Carrabba M, Pace F. The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia sympoms. J Psychosom Res 2004; 56: 213-16.
16. Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, et al. Validation of an Italia version of the Fibromyalgia Impact Questionnaire (FIQ-1) Clin Exp Rheumatol 2003; 21: 459-64.
17. Sarzi-Puttini P, Buskila D, Carrabba M, Doria A, Atzeni F. Treatment strategy in Fibromylgia Sindrome: where are we now? Semin. Arthritis Rheum 2008; 37: 353-65.
18. Cazzola M, Sarzi-Puttini P, Buskila D, Atzeni F. Pharmacological treatment of fibromyalgia. Reumatismo 2007; 59: 280-91.
19. McCain GA. A cost-effective approach to the diagnosis and treatment of fibromyalgia. Rheum Dis Clin North Am 1996; 22; 323-49.
20. Goossens ME, Rutten-van Molken MP, Vlaeyn JW, van der Linden SM. The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53: 688-95.
21. Walen HR, Cronan PA, Bibatti SM. Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 2001; 25: 39-47.
22. Oliver K, Cronan TA, Walen HR Tomita M. Effects of social support and education on health care costs for patients with fibromyalgia J Rheumatol 2001; 28: 2711-9.
23. Pfeiffer A, Thompson JM, Nelson A, Tuker S, Luedkte C, Finnie S, et al. Effects of a 1.5 day multidisciplinary outpatient treatment program for fibromyalgia: a pilot study Am J Phys Med. Rehabil 2003; 82: 186-91.
24. Buesing AR A conservative, cost-effective approach to fibromyalgia JAAPA 2005; 18: 32-7.
25. Ribinson RL, Jones ML. In search of pharmacoeconomic evaluations fof fibromyalgia treatments: a review Expert Opin Pharmacother 2006; 7: 1027-39.
26. Lind BK, Lafferty WE, Tyree PT, Diehr PK, Grembowski DE. Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage Arthritis Rheum 2007; 57: 71-6.
27. Zijlstra TR Braakman-Jansen LM, Taal E, Rasker JJ, van der Laar MA. Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free Rheumatology 2007; 46: 1454-59.
28. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multicentric study on service utilization and costs in fibromyalgia. Arthritis Rheum 1997; 40: 1560-70.
29. With KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada J Rheumatol 1999; 26: 885-9.
30. Robinson RL, Bimbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims J Rheumatol 2003; 30: 1318-25.
31. Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Healh services costs and their detrminats in women with fibromyalgia J Rheumatol 2004; 31: 1391-8.
32. Boonen A, van den Heuvel L, van Tubergen A, Goosens M, Severens JL, van der Heijde D, et al. Large differences in cost of illness and well being between patients with fibromyalgia, chronic low back pain or ankylosing spondylitis Ann Rheum Dis 2005; 64: 396-402.
33. Robinson RL, Bimbauem HG, Morley MA, Sisitsky T, Greeberg PE, Wolfe F. Depression and fibromyalgia: treatment and cost when diagnosed separately or concurrently. J Rheumatol 2004; 31: 1621-9.
34. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome Int J Clin Pract 2007; 61: 1498-508.
35. With LA, Bimbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fibromyalgia; medical comorbidity, healthcare costs and work loss. Occup Environ Med 2008; 50: 13-24.
36. www.istat.it
37. www.inps.it
38. www.inail.it
39. www.disabilitaincifre.it
40. Burkhardt C, Clark SR, Bennet RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18: 728-33.
41. Marsico A. Malattie reumatiche: impatto nel mondo del lavoro del 2000. atti del III Congresso Nazionale dei Reumatologi Ospedalieri Terme di Telese (BN) 9-11 dicembre 1999; 73-8.
42. Gerloni V, Ghirardini M, Fantini F. Assessmnt of non articular tenderness and prevalence of primary fibromyalgia syndrome in healthy Italian schoolchildren. Arthritis Rheum 1998; 41: 1405.
43. Baffigi A, Granata A, Sarzi-Puttini P, et al. Quality of life and mood disturbances in fibromyalgia and irritable bowel syndrome Ann Rheum Dis 2002: 61 (suppl 1); 151.
44. Mannerkorpi K. Exercise in fibromyalgia Curr Opin Rheumatol 2005; 17: 190-4.
45. Rooks DS, Silvermann CB, Kantrowitz FG. The effect of progressive strength training and aerobic exercise on muscle strength and cardiovascular fitness in women with fibromyalgia: a pilot study. Arthritis Rheum 2002; 47: 22-8.
46. www.it.geocities.com/fibroamici2004/
47. www.rheumatology.org/public/factscheets/fibromya-new.asp?aud=pat
48. www.afsafund.org
49. www.fmaware.org/site/PageServer
50. www.fmpartnership.org
51. www.sindromefibromiagica.it
52. www.weiss.de